Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction.
Pere PericasCaterina Mas-LladóMaria Francisca Ramis-BarcelóIsabel ValadrónMarta Noris MoraLucía Pasamar MárquezRosa González ColinoJosé Francisco Forteza AlbertíVicente Peral DisdierXavier RosselloPublished in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2021)
In addition to an improvement in systolic function parameters, patients with HFrEF receiving S-V improved their diastolic function. This echocardiographic improvement is particularly relevant in those patients with better NYHA class at 6-month follow-up.